US Broker Ratings

Wave Life Sciences Ltd. (WVE) Investor Outlook: High Upside Potential with 186.54% Growth Forecast

Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology company based in Singapore, is capturing investor attention with its innovative approach to RNA-based therapeutics. Despite operating in the volatile biotechnology..

agilon health, inc. (AGL) Investor Outlook: Exploring a 31% Potential Upside Amidst Challenging Metrics

For investors with a keen interest in the healthcare sector, agilon health, inc. (NYSE: AGL) presents an intriguing opportunity, with a potential upside of 31.38% based on current analyst ratings...

Pulse Biosciences, Inc. (PLSE) Stock Analysis: Exploring a 25% Potential Upside in the Healthcare Sector

Pulse Biosciences, Inc. (NASDAQ: PLSE) is making waves in the healthcare sector with its innovative approach to bioelectric medicine. Specializing in medical instruments and supplies, the company offers a range..

MiMedx Group, Inc. (MDXG) Stock Analysis: Potential 69% Upside Beckons Investors

MiMedx Group, Inc. (NASDAQ: MDXG) stands out in the biotechnology sector with its innovative approach to wound care and surgical solutions. Specializing in placental tissue allografts, the company leverages its..

Harrow, Inc. (HROW) Stock Analysis: 30% Upside Potential Amid Strong Buy Ratings

Harrow, Inc. (NASDAQ: HROW) has been making waves in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of $1.71 billion, this Nashville-based..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Navigating a 22% Revenue Growth with a Promising Pipeline

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH), a Canadian biopharmaceutical company, has garnered considerable attention in the healthcare sector, particularly within the biotechnology industry. Specializing in innovative therapies for autoimmune diseases, Aurinia’s..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring 17.13% Upside Potential in the Healthcare Sector

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a key player in the healthcare sector, operates within the niche of specialty and generic drug manufacturing. With a market capitalization of $1.3 billion, this..

Indivior PLC (INDV) Stock Analysis: Exploring a 25% Upside Potential with Strong Buy Ratings

Indivior PLC (INDV) is making waves in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a robust market capitalization of $2.9 billion, this United States-based..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: A 33% Upside in the Healthcare Sector

Establishment Labs Holdings Inc. (NASDAQ: ESTA) is capturing attention in the healthcare sector with its innovative approach to medical devices, particularly in the realm of aesthetic and reconstructive plastic surgeries...

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: Exploring a 30.94% Potential Upside Amidst Robust Revenue Growth

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), a prominent player in the healthcare sector, specifically within the biotechnology industry, stands as a compelling prospect for investors seeking exposure to innovative dermatological treatments...

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Evaluating Growth and Stability in the Healthcare Sector

Pediatrix Medical Group, Inc. (NYSE: MD), a key player in the healthcare sector, particularly in the medical care facilities industry, offers investors a unique proposition. Headquartered in Sunrise, Florida, and..

Neogen Corporation (NEOG) Stock Analysis: Navigating Opportunities Amidst Challenges in Diagnostics & Research

Investors with an eye on the healthcare sector, particularly in the Diagnostics & Research industry, might find Neogen Corporation (NEOG) a company of interest. With a market capitalization of $1.25..

AdaptHealth Corp. (AHCO) Stock Analysis: A 48% Upside Potential Amidst Healthcare Transformations

AdaptHealth Corp. (NASDAQ: AHCO) has piqued the interest of investors with its promising potential upside of 48.31%, driven by its strategic positioning within the healthcare sector. As a key player..

Evolent Health, Inc (EVH) Stock Analysis: A Promising 79.99% Upside Despite Current Challenges

Evolent Health, Inc. (NYSE: EVH), a key player in the healthcare industry’s health information services sector, presents an intriguing investment opportunity for those willing to navigate its current challenges. With..

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: Potential 93.73% Upside Amid Promising Clinical Trials

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a promising player in the biotechnology sector, has captured investor attention with its strong growth potential and an impressive target price range. With a current..

CONMED Corporation (CNMD) Stock Analysis: 22% Potential Upside Amidst Healthcare Sector Growth

Investors with an eye on the healthcare sector may find CONMED Corporation (NASDAQ: CNMD) an intriguing prospect. This U.S.-based medical device company, with a market capitalization of $1.55 billion, offers..

Vera Therapeutics, Inc. (VERA) Stock Analysis: Unpacking a 140% Potential Upside

Investors looking for opportunities in the biotechnology sector may find Vera Therapeutics, Inc. (NASDAQ: VERA) an intriguing proposition. With a market cap of $1.67 billion, this clinical-stage biotech company is..

Schrodinger, Inc. (SDGR) Stock Analysis: Is a 42.55% Potential Upside Worth the Investment?

Investors with an eye on technological innovations in healthcare might find Schrodinger, Inc. (NASDAQ: SDGR) an intriguing option. With a market cap of $1.45 billion, Schrodinger operates at the intersection..

Azenta, Inc. (AZTA) Stock Analysis: Navigating a 5.16% Potential Upside in the Healthcare Sector

For investors seeking opportunities in the healthcare sector, Azenta, Inc. (NASDAQ: AZTA) presents a compelling case with its diverse portfolio in the medical instruments and supplies industry. Headquartered in Burlington,..

Mineralys Therapeutics, Inc. (MLYS): A Biotech Stock with 12.82% Potential Upside – A Compelling Investment Opportunity?

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is making waves in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $3.01 billion, this clinical-stage biopharmaceutical company is focused..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds